Abstract
Current protocols for inducing osteogenic differentiation in mesenchymal stem/stromal cells (MSCs) in culture for tissue engineering applications depend on the use of biochemical supplements. However, standard in vitro culture conditions expose cells to ambient oxygen concentrations and high levels of serum (21% O2, 10% FBS) that do not accurately recapitulate the physiological milieu. While we and others have examined MSC behavior under hypoxia, the synergistic effect of low serum levels, such as those present in ischemic injury sites, on osteogenic differentiation has not been clearly examined. We hypothesized that a concomitant reduction of serum and O2 would enhance in vitro osteogenic differentiation of MSCs by more accurately mimicking the fracture microenvironment. We show that serum deprivation, in conjunction with hypoxia, potentiates osteogenic differentiation in MSCs. These data demonstrate the role of serum levels in regulating osteogenesis and its importance in optimizing MSC differentiation strategies.
Keywords: Mesenchymal stem cell, Osteogenic differentiation, Serum deprivation, Hypoxia
1. Introduction
Bone marrow-derived mesenchymal stem/stromal cells (MSCs) have been intensely investigated for orthopaedic tissue engineering applications for over two decades due to their availability, proliferative capacity, and multi-lineage differentiation potential (1–5). These cells are especially well-adapted for treatments seeking to resolve nonunion bone defects because endogenous MSCs undergo osteogenic differentiation to participate directly in fracture repair and bone regeneration (6). To this end, in vitro biochemical supplements such as ascorbic acid, β-glycerophosphate, and dexamethasone are typically used to differentiate MSCs down the osteoblastic lineage (7, 8) and enhance the efficacy of subsequent in vivo delivery (9, 10). However, critical-sized defects and nonunion fractures are poorly vascularized, resulting in an ischemic environment that is nutrient-deficient with oxygen levels as low as 0–3% (11, 12). Similarly, the MSC bone marrow niche is hypoxic, with an oxygen tension of less than 5% O2 (13). Therefore, standard culture conditions utilizing media supplemented with 10% fetal bovine serum (FBS) and ambient air (21% O2) (14) do not recapitulate the in vivo microenvironment, and phenotypic responses elicited under these conditions may deviate greatly from cellular behavior in situ.
We and others have shown that hypoxic culture has a significant effect on in vitro MSC behavior and osteogenic differentiation. For example, hypoxia-inducible factor 1-α (HIF-1α) is a transcription factor that is stabilized in the absence of oxygen and promotes cell survival and upregulates secretion of pro-angiogenic cytokines such as vascular endothelial growth factor (VEGF) (15, 16). Low oxygen tensions alone also stimulate proliferation and reduce senescence (17) while inhibiting osteogenesis in stromal cell populations (17–20). However, these studies are incomplete because they only take into account a single component of ischemia. Protocols targeting chondrogenic differentiation and maintenance of MSCs often call for the reduction or removal of FBS in order to mimic avascular cartilage (4, 14, 19), and induction media is typically supplemented with growth factors like transforming growth factor-β (TGF-β). However, the avascular cartilage niche contains levels of oxygen and nutrients that are lower than that of bone marrow (13) and may not be optimal for osteogenesis. The effects of simultaneous serum deprivation and hypoxia on MSC osteogenic differentiation have been poorly characterized and merit further study to develop improved protocols for in vitro differentiation prior to transplantation.
We hypothesized that combining serum reduction with hypoxia would more accurately simulate an ischemic defect site and enhance osteogenic differentiation of human MSCs compared to standard culture conditions. We investigated this hypothesis by incubating MSCs at varying oxygen tensions in media containing three different FBS concentrations, in the presence or absence of standard osteogenic supplements. We assessed osteogenic differentiation over time by measuring intracellular alkaline phosphatase (ALP) activity in cells exposed to each combination of stimuli. We also measured mineralization and calcium secretion of osteogenically-induced MSCs in serum-reduced and hypoxic conditions in vitro over the course of 3 weeks.
2. Materials and Methods
2.1 Cell culture
Human bone marrow-derived MSCs (Lonza, Walkersville, MD) were expanded without further characterization in growth medium (GM) composed of minimum essential alpha medium (α-MEM, Invitrogen, Carlsbad, CA), 10% FBS (JR Scientific, Woodland, CA) and 1% penicillin-streptomycin (P/S, Mediatech, Manassas, VA). Cells were expanded under standard culture conditions in a humidified incubator and used at passages 4–6. When described, osteogenic differentiation was induced by culturing cells in osteogenic medium (OM: GM supplemented with 10 mM β-glycerophosphate, 50 mg/mL ascorbate-2-phosphate, and 100 nM dexamethasone, Sigma-Aldrich, St. Louis, MO). Medium was replaced every 3 days.
To assess the effect of varying serum and oxygen levels on MSCs, cells were seeded in GM on 12-well tissue culture plates at 30,000 cells/cm2 and allowed to attach overnight. After 24h, medium was refreshed with GM or OM containing 1, 5, or 10% FBS and incubated in Heracell 150i tri-gas incubators (Thermo Scientific, Waltham, MA) at 1, 5, or 21% oxygen (n = 4 for every combination).
2.2 Biochemical characterization of osteogenic differentiation
Intracellular alkaline phosphatase (ALP) activity was quantified in MSCs at 7, 14, and 21 days as previously described (21). Briefly, cells were rinsed in phosphate buffered saline (PBS, Invitrogen) and collected in passive lysis buffer (Promega, Madison, WI). ALP activity was measured using a p-nitrophenyl phosphate (PNPP) assay and normalized to DNA quantified by a Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen).
After rinsing cells with PBS, calcium was collected from the bottom of each well in 0.9N H2SO4 using a cell scraper and incubated overnight at 37°C. Secreted calcium was quantified by reacting with o-cresolphthalein complexone as previously described (22) and assessed qualitatively using an Alizarin red stain (18).
2.3 Statistical analysis
Data are presented as mean ± standard error unless otherwise stated. Statistical analysis was performed using paired Student’s t-tests and one-way ANOVA with Tukey’s Multiple Comparison post-test where applicable. P values less than 0.05 were considered statistically significant.
3. Results
3.1 Serum reduction increases intracellular ALP activity in undifferentiated MSCs
At 7 days, MSCs cultured in GM containing 5% FBS exhibit trends for higher ALP activity compared to cells grown in 10% serum in both 1% and 5% O2 (Fig. 1A–B). In 21% O2, MSCs exposed to 5% serum have significantly higher ALP levels (Fig. 1C) and maintain the highest activity through 21 days of culture, although statistical significance was not achieved compared to 10% FBS at 3 weeks (Fig. 1F, I). Similarly, undifferentiated MSCs in 5% O2 have significantly higher ALP activity when supplemented with 5% FBS for 2 weeks compared to cells in full serum (Fig. 1E). After 21 days, cells in 5% serum have ALP activity that is greater than or equal to cells in standard media with 10% FBS at all oxygen tensions (Fig. 1G–I). MSCs in 1% FBS GM had the highest ALP levels compared to both other serum concentrations in 5% O2 at all time points (Fig. 1B, E, H).
Fig. 1.
MSCs cultured in GM express higher levels of intracellular ALP in medium containing reduced serum levels compared to media with 10% FBS. (A–C) At 7 days, (B) MSCs in 5% O2 have significantly higher ALP expression in GM supplemented with 1% FBS, while (C) cells in ambient oxygen have the highest ALP in 5% serum. Similarly, (D–F) at 14 days, GM containing either 1% or 5% serum produced significantly more ALP than cells in 10% FBS at both (E) 5% O2 and (F) 21% O2 tension. (G–I) After 3 weeks, MSCs in (G) 1% and (H) 5% O2 had highest ALP content in medium containing 1% FBS, with trends for higher ALP in 5% FBS at (H) 5% O2 and (I) ambient air. *p<0.05 vs 10% FBS, ***p<0.001 vs 10% FBS, ^^^p<0.001 vs 5% and 10% FBS (n = 4).
3.2 Serum deprivation potentiates the effect of osteogenic supplements on MSCs
As expected, MSCs cultured in the presence of standard osteogenic supplements had significantly higher ALP activity compared to cells in GM under every condition (Fig. 2). After 7 days, MSCs in 1% and 5% FBS had higher ALP levels than those in 10% serum under all oxygen tensions except 1% O2, where the 5% FBS group did not achieve statistical significance (Fig. 2A–C). Cells in reduced serum also expressed more ALP after 14 days in 5% O2 (Fig. 2E). After 3 weeks, MSCs in 5% O2 and OM containing 1% and 5% serum again had higher intracellular ALP compared to those cultured in 10% FBS (Fig. 2H). Similarly, cells in ambient air had significantly elevated ALP levels when supplemented with 5% FBS (Fig. 2I). Over the course of 21 days, MSCs cultured in 1% O2 and OM with 1% or 5% serum experienced significant cell loss and lack of proliferation (data not shown) and exhibited significantly lower osteogenic response (Fig. 2D, G). To avoid confounding results due to apoptosis and drastically lower cell number, 1% O2 conditions were not investigated in subsequent experiments.
Fig. 2.
MSCs cultured in OM express equal or higher levels of intracellular ALP in medium containing lower serum levels compared to cells in 10% FBS at all oxygen tensions. (A–C) At 7 days, (A) MSCs in 1% O2 have highest ALP expression in OM supplemented with 1% FBS. (B) Cells in 5% and (C) ambient oxygen have higher ALP in both 1% and 5% serum compared to 10%. Similarly, (D–F) at 14 days, (E) OM containing either 1% or 5% serum produced significantly more ALP than cells in 10% FBS at 5% O2. (G–I) After 3 weeks, MSCs in (G) 1% had highest ALP content in medium containing 1% FBS, with the highest ALP in 5% FBS at (H) 5% O2 and (I) ambient air. *p<0.05 vs 10% FBS, **p<0.01 vs 10% FBS, ***p<0.001 vs 10% FBS (n = 4).
3.3 MSC calcium secretion and matrix mineralization is enhanced in low serum
Compared to cells induced in OM containing full serum under 5% O2, MSCs cultured in 5% FBS under 5% O2 deposited significantly more mineral at 14 days and comparable amounts after 21 days as visualized by Alizarin red staining (Fig. 3A). Chemical quantification of calcium secretion after 3 weeks confirms that OM supplemented with 5% FBS results in the highest amount of mineralization at 5% O2 (Fig. 3B). Under atmospheric oxygen tension, calcium staining was slightly stronger in conventional OM at 14 days, but differences were not discernable by 21 days (Fig. 3C). In fact, quantification reveals that MSCs differentiated in 5% FBS produced twice as much calcium by the end of the study compared to those cultured in full serum (Fig. 3D).
Fig. 3.
OM-induced MSCs secrete more calcium under serum- and oxygen-reduced conditions compared to standard culture conditions. (A) Alizarin red staining reveals that MSCs cultured at 5% O2 and 5% FBS deposit the most total calcium at 14 and 21 days. These visual assessments are confirmed by (B) chemical quantification of samples at 21 days. (C) In 21% O2, MSCs deposit the most calcium in OM supplemented with 10% FBS at 14 days, but cells grown in 5% serum deposit a higher amount by 21 days. (D) Calcium quantification reveals that cells grown in 5% FBS secrete twice as much calcium at 21 days. **p<0.01 vs 10% FBS, ***p<0.001 vs. 1% and 10% FBS (n = 4).
4. Discussion
In vitro osteogenic differentiation protocols are commonly used in an effort to enhance the therapeutic effectiveness of MSCs delivered to nonunion and critical-sized bone defects. Osteogenic induction prior to implantation encourages MSCs to participate directly in bone repair by secreting and calcifying a collagen matrix (1, 3), thus improving functional in vivo outcomes (23). Standard osteogenic media supplements include ascorbic acid to promote extracellular matrix production, β-glycerophosphate as a source of phosphate ions for mineralization, and dexamethasone to stimulate transcription of osteoblast genes such as bone sialoprotein (7, 8, 14). However, these supplements are not found in situ, and MSCs dedifferentiate and regain their multipotency with the withdrawal of these cues in culture (24). More broadly, conventional cell culture conditions call for supplementation of basal media with 10% FBS and incubation in ambient 21% O2 to promote proliferation. These parameters are not physiologically relevant, especially compared to ischemic fractures and defects with little nutrient supply and oxygen tension below 1% (11, 25).
In an effort to more accurately recapitulate in vivo conditions, many groups have investigated the effect of hypoxia on MSC behavior in both 2D and 3D. Compared to 21% O2, hypoxic culture inhibits in vitro osteogenic differentiation of adipose-derived stromal cells (18), MIAMI cells (17), and MSCs (20, 26) while upregulating trophic factor production (18, 27). Nonetheless, the results of these studies may be misleading because they fail to consider the concomitant lack of serum that accompanies hypoxia in poorly vascularized tissue. Indeed, serum deprivation alone selects for bone marrow MSCs with a more pluripotent phenotype (28) and enhances their pro-angiogenic capacity (29). Due to the avascular nature of cartilage, serum-free and serum-reduced cultures have been investigated in the expansion and maintenance of chondrocytes (19, 30), but the collective effect of hypoxia and serum deprivation on MSC osteogenic differentiation has not been clearly reported. Therefore, we specifically examined the effect of multiple degrees of serum removal (1,5, 10% FBS) and oxygen levels (1,5, 21% O2) on biochemical markers of MSC osteogenesis over 3 weeks.
Even in the absence of inductive cues, MSCs in GM had elevated levels of intracellular ALP in low-serum cultures (Fig. 1). In 5% O2, ALP was consistently highest at 1% and lowest at 10% FBS over the course of 21 days (Fig. 1B, E, H). At ambient oxygen tension, media with 5% serum resulted in the highest cellular production of ALP at all time points (Fig. 1C, F, I). With the addition of osteogenic supplements, MSC ALP activity increased by at least an order of magnitude compared to cells in GM (Fig. 2), consistent with our previous findings (21). Also in agreement with our earlier work, MSCs in full serum exhibited reduced ALP activity when cultured in hypoxia. However, cells induced with media containing 1% and 5% FBS exhibited equal or higher levels of ALP compared to standard media under every oxygen tension and at every time point. These data demonstrating osteogenic differentiation in both the presence and absence of osteogenic supplements highlight the significant, complex interplay between serum and oxygen levels in governing cellular response, a phenomenon that merits further investigation.
In order to characterize functional in vitro osteogenic differentiation, we qualitatively and quantitatively assessed calcium deposition by osteogenically induced MSCs. As expected, cells conditioned in OM with 10% FBS secreted a calcium-rich matrix by 3 weeks as evidenced by heavy Alizarin red staining. MSCs in 5% serum under 5% O2 had noticeably stronger staining by 14 days and comparable staining by 21 days (Fig. 3A). Although MSCs in reduced serum did not mineralize their matrix as rapidly in ambient oxygen, the extent of calcium staining in 5% and 10% FBS was indistinguishable by 21 days (Fig. 3C). Biochemical quantification of calcium at 3 weeks confirmed that MSCs produce the most mineral in OM supplemented with 5% FBS regardless of oxygen tension. Notably, the 5% serum and 5% O2 condition elicited the strongest osteogenic response from MSCs, surpassing calcium secretion by cells in 21% O2.
These data clearly demonstrate that serum content and oxygen tension synergistically affect MSC differentiation and have significant implications for in vitro protocols for osteogenic induction. For example, many groups seek to increase the therapeutic potential of MSCs by preconditioning them under hypoxic environments prior to in vivo injection. This strategy upregulates pro-survival and angiogenic markers (31, 32), increases Wnt signaling (33), and improves in vivo osteogenesis (34). Given our findings, modulation of serum levels in these conditioning regimens could significantly enhance their efficacy and merits additional study.
Our results underscore the complexity of cellular response to environmental cues and the importance of considering multiple parameters when optimizing culture conditions. In this case, hypoxia alone is not sufficiently representative of an in vivo milieu – future studies seeking to reproduce a physiological environment in vitro must consider both FBS and oxygen content. From a practical standpoint, we have shown that a superior level of osteogenic differentiation can be achieved simply by halving the amount of costly FBS in culture medium. This in turn will allow for more cost-effective expansion and conditioning of larger numbers of MSCs for use in large-scale therapeutic applications.
Highlights.
Serum levels, in addition to hypoxia, have a significant effect on MSC osteogenic differentiation.
Both naïve and osteogenically induced MSCs exhibit higher osteogenic markers in reduced serum.
MSCs deposit the most calcium under 5% O2 in osteogenic media supplemented with 5% FBS.
Standard culture conditions (21% O2, 10% FBS) may not be optimal for MSC osteogenic differentiation.
Acknowledgements
This project was supported by grants from the National Institutes of Health 1RO3DE021704 and the Orthopaedic Research and Education Foundation (#13-006) to JKL and by the California Institute for Regenerative Medicine UC Davis Stem Cell Training Program (CIRM T1-00006, CIRM TG2-01163) to BYB.
Footnotes
Disclosures
The authors indicate no potential conflicts of interest.
References
- 1.Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. Journal of cellular biochemistry. 1994;56:283–294. doi: 10.1002/jcb.240560809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of cellular physiology. 2007;213:341–347. doi: 10.1002/jcp.21200. [DOI] [PubMed] [Google Scholar]
- 3.Caplan AI. New era of cell-based orthopedic therapies. Tissue engineering. Part B, Reviews. 2009;15:195–200. doi: 10.1089/ten.teb.2008.0515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of cellular and molecular medicine. 2004;8:301–316. doi: 10.1111/j.1582-4934.2004.tb00320.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147. doi: 10.1126/science.284.5411.143. [DOI] [PubMed] [Google Scholar]
- 6.Park D, Spencer JA, Koh BI, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell stem cell. 2012;10:259–272. doi: 10.1016/j.stem.2012.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. Journal of cellular biochemistry. 1998;71:55–62. doi: 10.1002/(sici)1097-4644(19981001)71:1<55::aid-jcb6>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- 8.Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of cellular biochemistry. 1997;64:295–312. [PubMed] [Google Scholar]
- 9.Viateau V, Guillemin G, Bousson V, et al. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2007;25:741–749. doi: 10.1002/jor.20352. [DOI] [PubMed] [Google Scholar]
- 10.Schmitt A, van Griensven M, Imhoff AB, Buchmann S. Application of stem cells in orthopedics. Stem cells international. 2012;2012:394962. doi: 10.1155/2012/394962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Brighton CT, Krebs AG. Oxygen tension of healing fractures in the rabbit. The Journal of bone and joint surgery. American volume. 1972;54:323–332. [PubMed] [Google Scholar]
- 12.Heppenstall RB, Grislis G, Hunt TK. Tissue gas tensions and oxygen consumption in healing bone defects. Clinical orthopaedics and related research. 1975:357–365. doi: 10.1097/00003086-197501000-00048. [DOI] [PubMed] [Google Scholar]
- 13.Ma T, Grayson WL, Frohlich M, Vunjak-Novakovic G. Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnology progress. 2009;25:32–42. doi: 10.1002/btpr.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Vater C, Kasten P, Stiehler M. Culture media for the differentiation of mesenchymal stromal cells. Acta biomaterialia. 2011;7:463–477. doi: 10.1016/j.actbio.2010.07.037. [DOI] [PubMed] [Google Scholar]
- 15.Dai Y, Xu M, Wang Y, Pasha Z, Li T, Ashraf M. HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. Journal of molecular and cellular cardiology. 2007;42:1036–1044. doi: 10.1016/j.yjmcc.2007.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Liu L, Yu Q, Lin J, et al. Hypoxia-inducible factor-1alpha is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem cells and development. 2011;20:1961–1971. doi: 10.1089/scd.2010.0453. [DOI] [PubMed] [Google Scholar]
- 17.D'Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone. 2006;39:513–522. doi: 10.1016/j.bone.2006.02.061. [DOI] [PubMed] [Google Scholar]
- 18.He J, Genetos DC, Yellowley CE, Leach JK. Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. Journal of cellular biochemistry. 2010;110:87–96. doi: 10.1002/jcb.22514. [DOI] [PubMed] [Google Scholar]
- 19.Li J, Pei M. Cell senescence: a challenge in cartilage engineering and regeneration. Tissue engineering. Part B, Reviews. 2012;18:270–287. doi: 10.1089/ten.TEB.2011.0583. [DOI] [PubMed] [Google Scholar]
- 20.Raheja LF, Genetos DC, Yellowley CE. The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells. Cells, tissues, organs. 2010;191:175–184. doi: 10.1159/000235679. [DOI] [PubMed] [Google Scholar]
- 21.Hoch AI, Binder BY, Genetos DC, Leach JK. Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PloS one. 2012;7:e35579. doi: 10.1371/journal.pone.0035579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Davis HE, Rao RR, He J, Leach JK. Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. Journal of biomedical materials research. Part A. 2009;90:1021–1031. doi: 10.1002/jbm.a.32169. [DOI] [PubMed] [Google Scholar]
- 23.Kang SW, Lee JS, Park MS, Park JH, Kim BS. Enhancement of in vivo bone regeneration efficacy of human mesenchymal stem cells. Journal of microbiology and biotechnology. 2008;18:975–982. [PubMed] [Google Scholar]
- 24.Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2004;18:980–982. doi: 10.1096/fj.03-1100fje. [DOI] [PubMed] [Google Scholar]
- 25.Binder BY, Genetos DC, Leach JK. Lysophosphatidic Acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. Tissue engineering. Part A. 2014;20:1156–1164. doi: 10.1089/ten.tea.2013.0487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Potier E, Ferreira E, Andriamanalijaona R, et al. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone. 2007;40:1078–1087. doi: 10.1016/j.bone.2006.11.024. [DOI] [PubMed] [Google Scholar]
- 27.Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. Journal of cellular biochemistry. 2006;98:1076–1084. doi: 10.1002/jcb.20886. [DOI] [PubMed] [Google Scholar]
- 28.Pochampally RR, Smith JR, Ylostalo J, Prockop DJ. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood. 2004;103:1647–1652. doi: 10.1182/blood-2003-06-1967. [DOI] [PubMed] [Google Scholar]
- 29.Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem cell research. 2011;6:215–225. doi: 10.1016/j.scr.2011.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Giannoni P, Pagano A, Maggi E, et al. Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2005;13:589–600. doi: 10.1016/j.joca.2005.02.015. [DOI] [PubMed] [Google Scholar]
- 31.Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. American journal of physiology. Cell physiology. 2010;299:C1562–C1570. doi: 10.1152/ajpcell.00221.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008;26:2173–2182. doi: 10.1634/stemcells.2007-1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Genetos DC, Toupadakis CA, Raheja LF, et al. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. Journal of cellular biochemistry. 2010;110:457–467. doi: 10.1002/jcb.22559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Volkmer E, Kallukalam BC, Maertz J, et al. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue engineering. Part A. 2010;16:153–164. doi: 10.1089/ten.TEA.2009.0021. [DOI] [PubMed] [Google Scholar]



